Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?
Employment as a health promotion intervention for persons with multiple sclerosis.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
The meninges: new therapeutic targets for multiple sclerosis.
Exome sequencing to find rare variants causing neurologic diseases.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Pages